TABLE 1.

VZV strains analyzed for this study

OriginNo. of samplesNo. of isolates
TotalClinicalTissue cultureFrom patients withWith site for:Of genotype:
VaricellaZosterPstI (ORF38)BglI (ORF54)EM (M1, M2)J
USA52272544849143811 (5, 6)3b
USA (Hawaii)3303003003b
Canada50500183250123810 (0,10)2
Mexico550505505 (0, 5)0
Chile220202111 (1, 0)0
Nicaragua110101101 (1, 0)0
DRC191901901919019 (19, 0)0
Chad550505505 (5, 0)0
Morocco110011101 (1, 0)0
Germany211292102102100
Iceland17170512171161 (0, 1)0
Czech Republic1101010100
Poland4404040400
Russia (Moscow)202002002002000
Belarus5505050500
Ukraine6606060600
Lithuania5505050500
Latvia990909181 (0, 1)0
Moldavia770707252 (2, 0)0
Estonia3303030300
Jordan1101010100
Kazakhstan1101010100
Russia (Novosibirsk)121201201201200
Japan2002016418200020
Oka vaccine202a2002002
Nepal550505505 (1, 4)0
India161601601616016 (6, 10)0
Bangladesh770707707 (7, 0)0
South China330303303 (0, 3)0
Western Australia1010010010737 (3, 4)0
Eastern Australia101001001001000
Lab strains303a3030300
Total32626759269573161252019530
  • a High-passage virus strain.

  • b J genotype strains all displayed the PstI BglI+ markers; all M strains were PstI+ BglI+; all E strains were PstI+ BglI.